Investor Overview

Update
Headquarters:
Bagsværd

Novo A/S is a Danish private limited liability company wholly owned by the Novo Nordisk Foundation, and the holding company of the Novo

Description

Update

Novo A/S is a Danish private limited liability company wholly owned by the Novo Nordisk Foundation, and the holding company of the Novo Group and as such the majority shareholder in the publicly listed companies Novo Nordisk A/S and Novozymes A/S.

Novo A/S was established in 1999 prior to the demerger of Novo Nordisk A/S, where Novozymes A/S was established as a stand-alone publicly listed company. Novo's purpose and objectives are to manage the Foundation's financial assets and to ensure the Foundation sufficient dividends to cover its grant obligations for medical and scientific research etc. in Scandinavia.

Novo A/S attains these objectives through: compliance with the rules and principles which are set out in the Articles of Association of the Novo Nordisk Foundation regarding exercise of the voting rights of A and B shares in Novo Nordisk A/S and Novozymes A/S, respectively, assurance that all... See More

Current Team (41)

Update

Investments (26)

Update

Offices/Locations (2)

Update
  • USA Visiting address

    Novo Ventures (US) Inc. 1700 Owens Street, Suite 540

    San Francisco, CA 94158

    USA

  • Office

    Krogshoejvej 41

    Bagsværd, DK-2880

    DNK